Aspen Neuroscience, Inc
Aspen Neuroscience, Inc., based in San Diego, CA, is pioneering the development of personalized cell therapies for Parkinson's disease through its innovative use of autologous induced pluripotent stem cells (iPSCs). With a commitment to leveraging patient-derived cells, the company aims to restore lost dopamine neurons and improve quality of life for those affected by the disease.
The company's lead product, ANPD001, has received IND clearance and Fast Track designation from the U.S. Food and Drug Administration and is currently undergoing investigation in the Phase 1/2a ASPIRO trial. Aspen Neuroscience is also advancing an automated biomanufacturing system to efficiently produce these personalized therapies while ensuring high-quality standards through proprietary genomic evaluations.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

